NEW YORK, March 9, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community.Today we are offering reports on BKD, EVHC, GEN, and KND which can be accessed for free by signing up to www.wallstequities.com/registration. Ahead of today's trading session, WallStEquities.com covers Brookdale Senior Living Inc. (NYSE: BKD), Envision
Brookdale Senior Living
On Thursday, shares in Brentwood, Tennessee headquartered Brookdale Senior Living Inc. recorded a trading volume of 2.13 million shares. The stock ended at $7.37, declining 1.34% from the last trading session. The Company's shares are trading below their 50-day moving average by 18.37%. Furthermore, shares of the Company, which owns and operates senior living communities in the US, have a Relative Strength Index (RSI) of 38.55.
On February 22nd, 2018, Brookdale Senior Living announced that its Board of Directors has: (i) formally concluded the strategic review process; (ii) appointed CFO Lucinda M. Baier as President and CEO and as a Director to succeed T. Andrew Smith; and (iii) elected Lee S. Wielansky as Non-Executive Chairman to succeed Executive Chairman Daniel A. Decker, who has chosen to retire from the Board now that the strategic review process has been concluded.
On February 27th, 2018, research firm RBC Capital Markets downgraded the Company's stock rating from 'Outperform' to 'Sector Perform'. Get the full research report on BKD for free by clicking below at:
Nashville, Tennessee-based Envision Healthcare Corp.'s stock finished yesterday's session 0.07% higher at $42.79. A total volume of 3.35 million shares was traded, which was above their three months average volume of 2.71 million shares. The Company's shares have gained 23.31% in the last month and 37.02% over the previous three months. The stock is trading above its 50-day moving average by 17.66%. Furthermore, shares of Envision Healthcare, which through its subsidiaries, provides various healthcare services in the US, have an RSI of 79.53.
On February 27th, 2018, Envision Healthcare reported its results for the three months ended December 31st, 2017. Net revenue from continuing operations for Q4 2017 was $2.00 billion, net earnings from continuing operations attributable to common stockholders were $137.8 million, and adjusted EBITDA from continuing operations was $211.4 million. Net cash flow from operations, less distributions to non-controlling interests and excluding transaction costs, was $210.9 million for the quarter. The free technical report on EVHC can be accessed at:
On Thursday, shares in Kennett Square, Pennsylvania headquartered Genesis Healthcare Inc. jumped 4.41%, ending the day at $1.42. The stock recorded a trading volume of 1.09 million shares, which was above its three months average volume of 681,620 shares. The Company's shares have surged 48.82% in the last month and 86.84% in the previous three months. The stock is trading 40.70% and 21.07% above its 50-day and 200-day moving averages, respectively. Moreover, shares of Genesis Healthcare have an RSI of 62.56.
On March 06th, 2018, Genesis Healthcare announced that it has closed on its previously announced $555 million asset-based lending facility and the amended and expanded term loan, which includes an additional $40 million tranche. Sign up for free on Wall St. Equities and claim the latest report on GEN at:
Louisville, Kentucky headquartered Kindred Healthcare Inc.'s shares ended the day flat at $9.35 with a total trading volume of 577,358 shares. The stock has gained 1.63% in the last month, 29.86% over the previous three months, and 8.09% over the past year. The Company's shares are trading 0.69% above their 50-day moving average and 8.18% above their 200-day moving average. Additionally, shares of Kindred Healthcare, which provides healthcare services in the US, have an RSI of 56.58.
On February 28th, 2018, Kindred Healthcare announced its results for Q4 and full year ended December 31st, 2017. For Q4 2017, consolidated revenues were $1.5 billion, GAAP loss from continuing operations was $(135.4) million, EBITDA was a loss of $(192.8) million, and GAAP operating cash flows were $67.2 million. For the full year, consolidated revenues were $6.0 billion, GAAP loss from continuing operations was $(247.2) million, EBITDA was a loss of $(61.6) million, and GAAP operating cash flows were $75.7 million. See the free research coverage on KND at:
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:Email: firstname.lastname@example.org Phone number: +21-32-044-483Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
View original content:http://www.prnewswire.com/news-releases/quotidian-technical-highlights-on-selected-long-term-care-facilities-stocks----brookdale-senior-living-envision-healthcare-genesis-healthcare-and-kindred-healthcare-300611416.html
SOURCE Wall St. Equities
Subscribe to our Free Newsletters!
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...
Are you gluten intolerant? Stay away from gluten allergy and celiac disease by shifting to ...
Moxetumomab pasudotox-tdfk is used to treat hairy cell leukemia (a form of chronic lymphocytic ...View All